Apotex Moves First On Combigan As US Patent Expiry Looms
10 Orange Book Listed Patents Will Expire On 19 April
Apotex has moved first on Allergan’s Combigan, introducing a US authorized generic as the clock ticks on the originator’s IP. Sandoz is among ANDA sponsors seemingly waiting for patent protection to lapse.
